Tiotropium Bromide Inhalation Powder

DRUG3 trials

Sponsors

Boehringer Ingelheim, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease (COPD)Pulmonary Disease, Chronic Obstructive

Phase 1

A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot)

Active, not recruitingNCT06326671

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chronic Obstructive Pulmonary Disease

Start: 2024-02-28End: 2024-04-30Updated: 2024-03-29

A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditions

Active, not recruitingNCT06487416

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chronic Obstructive Pulmonary Disease (COPD)

Start: 2024-06-10End: 2024-10-31Updated: 2024-07-05

Phase 4

Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease

CompletedNCT00106821

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2004-06-30Updated: 2013-11-01